About: A cohort study of 223 patients explores the clinical risk factors for the severity diagnosis of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A cohort study of 223 patients explores the clinical risk factors for the severity diagnosis of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A cohort study of 223 patients explores the clinical risk factors for the severity diagnosis of COVID-19
Creator	Wang, Lin Wu, Zou, Wenbin Huang, Yongsheng Li, ，dan Lyu, Xiaoyu Wang, Yujun Wei, Yingxin Wu, Xiaowei Yingxin, Wei
Source	MedRxiv
abstract	BACKGROUND: Coronavirus Disease 2019 (COVID-19) has recently become a public emergency and a worldwide pandemic. The clinical symptoms of severe and non-severe patients vary, and the case-fatality rate (CFR) in severe COVID-19 patients is very high. However, the information on the risk factors associated with the severity of COVID-19 and of their prognostic potential is limited. METHODS: In this retrospective study, the clinical characteristics, laboratory findings, treatment and outcome data were collected and analyzed from 223 COVID-19 patients stratified into 125 non-severe patients and 98 severe patients. In addition, a pooled large-scale meta-analysis of 1646 cases was performed. RESULTS: We found that the age, gender and comorbidities are the common risk factors associated with the severity of COVID-19. For the diagnosis markers, we found that the levels of D-dimer, C-reactive protein (CRP), lactate dehydrogenase (LDH), procalcitonin (PCT) were significantly higher in severe group compared with the non-severe group on admission (D-Dimer: 87.3% vs. 35.3%, P<0.001; CRP, 65.1% vs. 13.5%, P<0.001; LDH: 83.9% vs. 22.2%, P<0.001; PCT: 35.1% vs. 2.2%, P<0.001), while the levels of aspartate aminotransferase (ASP) and creatinine kinase (CK) were only mildly increased. We also made a large scale meta-analysis of 1646 cases combined with 4 related literatures, and further confirmed the relationship between the COVID-19 severity and these risk factors. Moreover, we tracked dynamic changes during the process of COVID-19, and found CRP, D-dimer, LDH, PCT kept in high levels in severe patient. Among all these markers, D-dimer increased remarkably in severe patients and mostly related with the case-fatality rate (CFR). We found adjuvant antithrombotic treatment in some severe patients achieved good therapeutic effect in the cohort. CONCLUSIONS: The diagnosis markers CRP, D-dimer, LDH and PCT are associated with severity of COVID-19. Among these markers, D-dimer is sensitive for both severity and CFR of COVID-19. Treatment with heparin or other anticoagulants may be beneficial for COVID-19 patients.
has issue date	2020-04-24(xsd:dateTime)
bibo:doi	10.1101/2020.04.18.20070656
has license	medrxiv
sha1sum (hex)	2267bdcf351231fdafbab20717a3aa04b69385bf
schema:url	https://doi.org/10.1101/2020.04.18.20070656
resource representing a document's title	A cohort study of 223 patients explores the clinical risk factors for the severity diagnosis of COVID-19
resource representing a document's body	covid:2267bdcf351231fdafbab20717a3aa04b69385bf#body_text
is schema:about of	named entity '2019' named entity 'prognostic' named entity 'SEVERITY' named entity 'CASE' named entity 'symptoms' named entity 'patients' named entity 'However' named entity 'prognostic' named entity 'case-fatality rate' named entity 'COVID' named entity 'public emergency' named entity 'Central Hospital of Wuhan' named entity 'Clinical features' named entity 'D-dimer' named entity 'clinical characteristics' named entity 'Wuhan' named entity 'risk factors' named entity 'cohort study' named entity 'COVID-19' named entity 'Severe Acute Respiratory Syndrome Coronavirus 2' named entity 'cough' named entity 'antiviral therapy' named entity 'CT images' named entity 'MERS' named entity 'SARS-like coronaviruses' named entity 'fixed-effects' named entity 'CRP' named entity 'clinical characteristics' named entity 'D-dimer' named entity 't-test' named entity 'pneumonia' named entity 'meta-analysis' named entity 'COVID' named entity 'cough' named entity 'clinical symptoms' named entity 'LDH' named entity 'CFR' named entity 'risk factors' named entity 'COVID-19' named entity 'fever' named entity 'informed consent' named entity 'Fisher's exact test' named entity 'CRP' named entity 'LDH' named entity 'severe acute respiratory syndrome coronavirus' named entity 'COVID-19' named entity 'antithrombotic' named entity 'COVID-19' named entity 'adjuvant' named entity 'epidemiological' named entity 'COVID-19' named entity 'COVID' named entity 'SARS-COV-2' named entity 'CFR' named entity 'January 1' named entity 'COVID' named entity 'respiratory symptoms' named entity 'prognostic' named entity 'dyspnea' named entity 'CFR' named entity 'inflammation' named entity 'infection' named entity 'organ dysfunction' named entity 'lactate dehydrogenase' named entity 'Fever' named entity 'RT-PCR' named entity 'chest CT' named entity 'CRP' named entity 'LDH' named entity '2, 3' named entity 'clinical features' named entity 'D-dimer' named entity 'fatigue' named entity 'COVID-19' named entity 'therapeutic effect' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software